Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Walter Robinson is active.

Publication


Featured researches published by Walter Robinson.


The New England Journal of Medicine | 1999

Is informed consent always necessary for randomized, controlled trials? .

Robert D. Truog; Walter Robinson; Adrienne G. Randolph; Alan H. Morris

Consider this paradox: if a physician reads a case report about a novel method of ventilation for critically ill patients and wants to try it in the next several patients with respiratory failure h...


Critical Care Medicine | 2003

Role of brain death and the dead-donor rule in the ethics of organ transplantation.

Robert D. Truog; Walter Robinson

The “dead-donor rule” requires patients to be declared dead before the removal of life-sustaining organs for transplantation. The concept of brain death was developed, in part, to allow patients with devastating neurologic injury to be declared dead before the occurrence of cardiopulmonary arrest. Brain death is essential to current practices of organ retrieval because it legitimates organ removal from bodies that continue to have circulation and respiration, thereby avoiding ischemic injury to the organs. The concept of brain death has long been recognized, however, to be plagued with serious inconsistencies and contradictions. Indeed, the concept fails to correspond to any coherent biological or philosophical understanding of death. We review the evidence and arguments that expose these problems and present an alternative ethical framework to guide the procurement of transplantable organs. This alternative is based not on brain death and the dead-donor rule, but on the ethical principles of nonmaleficence (the duty not to harm, or primum non nocere) and respect for persons. We propose that individuals who desire to donate their organs and who are either neurologically devastated or imminently dying should be allowed to donate their organs, without first being declared dead. Advantages of this approach are that (unlike the dead-donor rule) it focuses on the most salient ethical issues at stake, and (unlike the concept of brain death) it avoids conceptual confusion and inconsistencies. Finally, we point out parallel developments, both domestically and abroad, that reflect both implicit and explicit support for our proposal.


Genetics in Medicine | 2011

Research use of leftover newborn bloodspots: Attitudes of Canadian geneticists regarding storage and informed consent requirements

Julie Richer; Musie Ghebremichael; Albert E. Chudley; Walter Robinson; Benjamin S. Wilfond; Mildred Z. Solomon

Purpose: Leftover newborn spots can provide a powerful research tool as a population-wide DNA bank. Some provinces/states store them for more than 20 years; however, parents are usually not informed of the retention of leftover newborn spots. To examine the opinions of Canadian geneticists regarding permission for leftover newborn spots storage for research purposes and the associated risks, a web-based survey was distributed to all members of the Canadian College of Medical Geneticists with a valid e-mail address (n = 209) and completed by 78 respondents (37%).Results: The majority of respondents (73%) favored opt-out notification for retention of samples that would be held for longer than 2 years. For research on multifactorial conditions using leftover newborn spots originally banked without parental permission, geneticists favored different types of permission depending on the level of identifiable information attached to samples. Thirty-eight percent were concerned that information pamphlets that state that leftover newborn spots will be stored and may be “a source of DNA for research” would lead to a decreased participation in newborn screening. Twenty-eight percent believed that group stigma or family anxiety was likely to result from using nonidentified leftover newborn spots to study multifactorial conditions.Conclusion: The concerns of this knowledgeable cohort supports the critical importance of public engagement about both the potential risks and societal benefits associated with the use of leftover newborn spots in research as policy for leftover newborn spots is developed.


Archive | 2016

Ethical Considerations in Chronic Invasive Mechanical Ventilation in Pediatrics

Walter Robinson

Placement of a tracheotomy and chronic ventilation of a child is a common enough decision in pediatric intensive care, but the decision echoes through the rest of the child’s and the family’s life. This chapter will address the ethical issues surrounding chronic ventilation by means of tracheostomy, including the initial decision to place the tracheostomy, informed consent of parents, assessment of quality of life and its role in making the decision to institute mechanical ventilation, and future decisions on end-of-life care. In addition, special considerations of ethics in two populations, teenagers with intact cognition and infants with severe cognitive deficits, will be examined.


Pediatrics | 2011

NIH consensus development conference statement: Inhaled nitric-oxide therapy for premature infants

F. Sessions Cole; Claudia Alleyne; John Barks; Robert J. Boyle; John L. Carroll; Deborah Dokken; William H. Edwards; Michael K. Georgieff; Katherine E. Gregory; Michael V. Johnston; Michael S. Kramer; Christine Mitchell; Josef Neu; DeWayne M. Pursley; Walter Robinson; David H. Rowitch


The New England Journal of Medicine | 2000

Pharmacologic Paralysis and Withdrawal of Mechanical Ventilation at the End of Life

Robert D. Truog; Jeffrey P. Burns; Christine Mitchell; Judy Johnson; Walter Robinson


NIH consensus and state-of-the-science statements | 2010

NIH consensus development conference

F. Sessions Cole; Claudia Alleyne; John Barks; Robert J. Boyle; John L. Carroll; Deborah Dokken; William H. Edwards; Michael K. Georgieff; Katherine E. Gregory; Michael V. Johnston; Michael S. Kramer; Christine Mitchell; Josef Neu; DeWayne M. Pursley; Walter Robinson; David H. Rowitch


NIH consensus and state-of-the-science statements | 2010

NIH consensus development conference: Inhaled nitric oxide therapy for premature infants.

F. Sessions Cole; Claudia Alleyne; John Barks; Robert J. Boyle; John L. Carroll; Deborah Dokken; William H. Edwards; Michael K. Georgieff; Katherine E. Gregory; Michael V. Johnston; Michael S. Kramer; Christine Mitchell; Josef Neu; DeWayne M. Pursley; Walter Robinson; David H. Rowitch


Anesthesiology | 1999

Informed consent for research: the achievements of the past and the challenges of the future.

Robert D. Truog; Walter Robinson


Journal of Clinical Anesthesia | 1999

Bragdon v. Abbott.

Liang B; Walter Robinson; Robert D. Truog

Collaboration


Dive into the Walter Robinson's collaboration.

Top Co-Authors

Avatar

Robert D. Truog

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. Sessions Cole

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

John Barks

University of Michigan

View shared research outputs
Top Co-Authors

Avatar

John L. Carroll

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Josef Neu

University of Florida

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge